powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1487016952
Jeffrey Wei
Endocrinology
Ventura,
CA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
PRESCRIBING · PART D · 2024
Total Rx claims
2,603
Beneficiaries
—
Total drug cost
$1.2M
Distinct drugs
37
Brand share
58.1%
Top prescribed drugs
Levothyroxine Sodium
339 claims
Semaglutide
281 claims
Metformin Hcl
204 claims
Metformin Hcl
129 claims
Tirzepatide
106 claims
QUALITY · MIPS · 2024
Final MIPS score
87.5
Quality
79.4
Cost
73.7
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.53%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$429
Payment records
13
By payment type
Food and Beverage
$332
Long term medical supply or device loan
$65
Education
$32
Top paying entities
Food and Beverage
$332
Long term medical supply or device loan
$65
Education
$32
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,719
Unique beneficiaries
—
Total services
29,516
Distinct HCPCS
10
Medicare payment
$422K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 633 Endocrinology providers in CA — top quintile (cohort median 1,164).